NeuCyber NeuroTech sits in China’s state-backed implantable BCI ecosystem, with Beinao-1 focused on assistive control for patients with severe motor impairment. Its positioning is notable for using a semi-invasive cortical-surface approach as part of a broader national push toward domestic BCI development.